THE CANADIAN DRUG AGENCY: THE FEDERAL GOVERNMENT’S NATIONAL PHARMACARE AGENDA GIVES CADTH A NEW NAME AND AN EXPANDED MANDATE
May-June 2024William Dempster and Trevor Richter | Value & Outcomes Spotlight (ISPOR)
mai 2024
HOW WILL NEW DRUGS FOR OBESITY AND ALZHEIMER’S DISEASE BE RECEIVED BY CANADIAN PUBLIC PAYERS?
May 2023Don Sancton | Provincial Reimbursement Advisor
CANADIANS NEED ACCESS TO MEDICINES – AFTER THAT, THERE’S LITTLE AGREEMENT ON PHARMACARE PLANS
May 2024Don Sancton | Provincial Reimbursement Advisor
PROFILES IN REIMBURSEMENT – CONTRIBUTIONS MADE BY THE BRITISH COLUMBIA PHARMACEUTICAL, LABORATORY AND BLOOD SERVICES DIVISION (BC PLBSD)
May 2024Gerry Jeffcott | Provincial Reimbursement Advisor